Ephedra Back On Regulatory Radar As Supplement Adulterant
This article was originally published in The Tan Sheet
FDA acknowledges that enforcement activity on ephedra has been a lower priority than other adulterants since the agency banned ephedrine alkaloids in supplements in 2004. “The presumption was that it was banned and people were abiding by the law,” says FDA supplement official Daniel Fabricant.
You may also be interested in...
ED-spiked supplement importers identified; FDA and FTC act on GAO outreach suggestion; ephedra-like rulemaking needed for yohimbe – study; and God's book among violative claims by Florida firm.
DEA says more kratom was seized from US firms in the first half of 2016 than in any previous year, but the seizures came two years after FDA imposed an import alert to stop shipments and three years after the agency stumbled out of the gate in determining whether the ingredient could be used in supplements.
CFSAN warns seven companies about products marketed as supplements with labeling listing methylsynephrine as a dietary ingredient. The center also warned two of the firms their products contained other ingredients FDA previously began forcing off the market, DMAA and DMBA.